Prediabetes in End Stage Renal Disease on Dialysis
NCT07337083 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 262
Last updated 2026-01-13
Summary
Prediabetes is a highly prevalent condition, affecting about one-third of adults in the United States Patients with prediabetes have an increased risk for diabetes, with 2% to 10% progressing to diabetes each yea Although prediabetes is frequently considered an intermediary stage in the progression between normoglycemia and diabetes, many individuals may have prediabetes for several years, while some may never progress.
Conditions
- Screening
- Pre Diabetic
- Chronic Renal Failure (CRF)
- Dialysis Patients
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-13
- Primary Completion
- 2025-09-13
- Completion
- 2025-10-12
Countries
- Egypt
Study Locations
More Related Trials
-
Diabetic Patients With End-Stage Renal Disease
NCT00435786 ·Status: COMPLETED
-
Acute Kidney Injury in Patients on Dapagliflozin and Other Antidiabetic Medications
NCT02695082 ·Status: COMPLETED
-
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease
NCT06982079 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
NCT06532682 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
GLUcose Transport and REnalPROtection in Chronic Kidney Disease
NCT05998837 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prevent Diabetic Kidney Disease Among Egyptians
NCT06071208 ·Status: NOT_YET_RECRUITING
-
The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease
NCT06528405 ·Status: RECRUITING ·Phase: PHASE2
-
SGLT2i in Diabetic Patients with Renal Transplantation
NCT06731231 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
NCT03983551 ·Status: COMPLETED ·Phase: PHASE4
-
Kidney Biopsy Indications in Type 2 Diabetes Patients
NCT04006028 ·Status: COMPLETED
-
Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)
NCT01829256 ·Status: COMPLETED ·Phase: NA
-
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
NCT05378282 ·Status: COMPLETED
-
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
NCT03015480 ·Status: COMPLETED ·Phase: NA
-
Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study
NCT05713851 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Renal Impairment in Type 2 Diabetic Subjects
NCT00554450 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients
NCT03573102 ·Status: UNKNOWN ·Phase: PHASE4
-
Insulin Dosing in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis
NCT02083133 ·Status: COMPLETED
-
Risk of CKD in Diabetic Patients With MAFLD
NCT06304844 ·Status: NOT_YET_RECRUITING
-
Sodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diabetic Chronic Kidney Disease Patients
NCT07302464 ·Status: COMPLETED
-
Asymptomatic Bacteriuria, Urinalysis Abnormality at the Initiation of SGLT2 Inhibitors and UTI Risk
NCT05520684 ·Status: UNKNOWN
-
Decision Impact Trial of KidneyIntelX
NCT04791358 ·Status: RECRUITING
-
Safety and Dose Finding Study of Xigris in Hemodialysis Patients
NCT01227187 ·Status: COMPLETED ·Phase: PHASE2
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
NCT00342927 ·Status: ACTIVE_NOT_RECRUITING
-
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
NCT06217302 ·Status: RECRUITING ·Phase: PHASE3
-
Reducing Risk of Diabetic Ketoacidosis in Type 1 Diabetes and Kidney Disease Using Continuous Ketone Monitoring
NCT07325201 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2